What is the appropriate management for a 24‑year‑old woman with hirsutism, irregular menstrual cycles (including two periods in one month and prolonged intervals), elevated total testosterone and free testosterone, elevated dehydroepiandrosterone sulfate, normal thyroid‑stimulating hormone, normal hemoglobin A1c, and normal 17‑hydroxyprogesterone?

Management of Suspected PCOS with Hirsutism and Irregular Menses

This 24-year-old woman most likely has polycystic ovary syndrome (PCOS), and should be started on combined oral contraceptive pills as first-line therapy, with the addition of an antiandrogen (spironolactone) after 6 months if hirsutism remains bothersome. 1, 2

Diagnostic Considerations

The clinical presentation strongly suggests PCOS given the constellation of:

• Hirsutism with elevated total testosterone (73 ng/dL) and free testosterone (9.3 pg/mL) 3
• Irregular menstrual cycles (oligomenorrhea with variable intervals) 3
• Elevated DHEA-S (489 μg/dL) indicating androgen excess 4
• Normal 17-hydroxyprogesterone, which effectively rules out nonclassic congenital adrenal hyperplasia 1, 2
• Normal TSH and HbA1c, excluding thyroid dysfunction and overt diabetes 4

PCOS and idiopathic hyperandrogenism together account for more than 85% of hirsutism cases in premenopausal women. 4 The gradual onset since adolescence (rather than rapid progression over months) and absence of virilization signs make an androgen-secreting tumor highly unlikely. 4

First-Line Management Approach

Lifestyle Modification

Weight loss of as little as 5% of initial body weight improves both metabolic and reproductive abnormalities in PCOS. 5 This should be the foundation of treatment, as it directly impacts ovarian function and androgen levels. 5 Exercise programs, even without weight loss, are expected to have positive metabolic effects. 5

Pharmacologic Therapy for Hirsutism

Combined oral contraceptive pills (OCPs) are the recommended initial pharmacologic therapy for women not seeking pregnancy. 1, 2 OCPs work by:

• Suppressing ovarian androgen production through gonadotropin suppression 6
• Increasing sex hormone-binding globulin (SHBG), thereby reducing free testosterone 6
• Potentially decreasing adrenal androgen production 6

Third-generation OCPs containing newer progestogens or cyproterone acetate are particularly effective, with long-term use (>12 cycles) curing mild-to-moderate hirsutism and improving severe cases. 6

Adding Antiandrogen Therapy

If patient-important hirsutism persists after 6 months of OCP monotherapy, add an antiandrogen. 1, 2 The combination of an antiandrogen with ovarian suppression (via OCP) is the most effective medical approach. 5

Spironolactone is the first-line antiandrogen choice: 7

• Dosing: 50-200 mg daily (higher doses more effective but with increased side effects) 7, 6
• Mechanism: Blocks androgen receptors 6
• Must be combined with adequate contraception due to risk of feminization of male fetuses 1, 8

Alternative antiandrogens if spironolactone is not tolerated: 7

• Finasteride 5 mg daily (5α-reductase inhibitor; less effective but well-tolerated) 7, 6
• Cyproterone acetate (not available in the US; very effective at 12.5-50 mg/day) 6
• Flutamide (second-line due to hepatotoxicity risk; requires liver enzyme monitoring) 7, 6

Topical Therapy

Topical eflornithine hydrochloride cream is FDA-approved for hirsutism and can be used as adjunctive therapy. 5 It works as monotherapy for mild hirsutism or enhances results when combined with systemic therapy. 7

What NOT to Use

Do not use insulin-sensitizing agents (metformin, thiazolidinediones) for hirsutism treatment alone. 1, 8, 7 While these agents improve metabolic parameters and ovulation frequency in PCOS, monotherapy with insulin sensitizers does not significantly improve hirsutism. 7 They are not recommended when hirsutism is the sole indication. 7

Direct Hair Removal Methods

For women desiring additional cosmetic benefit beyond pharmacotherapy, laser/photoepilation is the preferred direct hair removal method. 1, 8 Alexandrite and diode lasers are particularly effective for permanent hair reduction. 7 Electrolysis provides permanent hair removal but may be impractical for large areas. 5

Temporary methods (shaving, plucking, waxing) are acceptable but require ongoing maintenance. 7, 4

Critical Timing Expectations

A minimum of 6 months of pharmacologic therapy is required before assessing treatment response or switching therapies. 7, 4 This reflects the hair growth cycle duration. Patients must understand that lifelong treatment is often necessary for sustained benefit. 7

Common Pitfalls to Avoid

• Never use antiandrogen monotherapy without adequate contraception due to teratogenic risk 1, 8
• Do not expect rapid results—set realistic expectations about the 6-month minimum treatment duration 7, 4
• Avoid high-dose flutamide without careful liver enzyme monitoring due to hepatotoxicity risk 7, 6
• Do not rely solely on insulin sensitizers for hirsutism management 1, 8, 7